Allergies News and Research

Latest Allergies News and Research

Researchers develop highly scalable, accurate antibody test for COVID-19

An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use.

12 Sep 2020

New study brings researchers closer to a universal COVID-19 antibody test

A new study released by Houston Methodist takes researchers a significant step closer to developing a uniform, universal COVID-19 antibody test.

11 Sep 2020

Most adults wary of taking any vaccine approved before the election

The public is deeply skeptical about any coronavirus vaccine approved before the November election, and only 42% would be willing to get a vaccine in that scenario, according to a new poll.

10 Sep 2020

Allergic immune response against bacteria is not pathological but protective

Allergy is one of the most common diseases in Europe, it is estimated that more than 150 million Europeans suffer from recurring allergies and by 2025 this could have increased to half of the entire European population.

9 Sep 2020

Researchers receive $1.9 million federal grant to find Lyme disease vaccine

Pesky, yet dangerous ticks are no longer latching exclusively onto hunters and outdoor enthusiasts. Milder winters and disrupted habitats have driven them out of the woods, with Lyme disease cases in the United States tripling since the late 1990s.

9 Sep 2020

Babies born in the fall more likely to experience all conditions associated with atopic march

Food allergies are on the rise, with more than five million children, about two kids in every school classroom, now suffering from allergy to at least one food.

9 Sep 2020

Convalescent plasma could be an effective treatment for children with COVID-19

Early findings from researchers at Children's Hospital of Philadelphia (CHOP) show that convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.

9 Sep 2020

Researchers discuss the role of chemical senses in disease and social interactions in humans, animals

Across 5 days in August (3rd-7th), scientists from around the world gathered virtually to present and discuss new information on the role of the chemical senses in disease, nutrition, and social interactions in humans and animals.

9 Sep 2020

Will Labor Day weekend bring another holiday COVID surge? Jury’s out.

Hopefully, summer won’t end the way it began. Memorial Day celebrations helped set off a wave of coronavirus infections across much of the South and West. Gatherings around the Fourth of July seemed to keep those hot spots aflame.

4 Sep 2020

As threat of valley fever grows beyond the Southwest, push is on for vaccine

One New Year's Day, Rob Purdie woke up with a headache that wouldn't quit. Vision problems, body aches and a slight fever followed. At the emergency room, the Bakersfield, California, resident was given antibiotics, which didn't touch his symptoms.

4 Sep 2020

Phase 3 study to test efficacy of new treatment for pediatric acute-onset neuropsychiatric syndrome

Octapharma has launched a phase 3, multi-center superiority study to compare the effectiveness of PANZYGA (immune globulin intravenous, human - ifas) 10% Liquid Preparation versus placebo in patients with pediatric acute-onset neuropsychiatric syndrome (PANS).

3 Sep 2020

UChicago Medicine launches clinical trial to test the potential of antibody against SARS-CoV-2

The University of Chicago Medicine is launching a clinical trial to examine the potential of an antibody against the SARS-CoV-2 spike protein for treating COVID-19, the disease caused by the novel coronavirus.

3 Sep 2020

Scientists identify genetic risk factors underlying penicillin allergy

Penicillin, a life-saving medicine, is the most common cause of drug allergy, with clinical manifestations ranging from temporary skin reactions to life-threatening systemic syndromes.

3 Sep 2020

HIV and HCV testing at drug detoxification centers can help identify persons at-risk during opioid epidemic

With an increase in HIV and HCV infections as a consequence of the ongoing opioid epidemic, Boston Medical Center researchers found that only a small number of those who test positive for those infections at a drug detoxification center followed up for a clinical visit after their test.

3 Sep 2020

VUMC launches clinical trial of promising COVID-19 treatments in outpatient setting

Vanderbilt University Medical Center is launching a clinical trial of promising treatments for COVID-19 in the outpatient setting.

2 Sep 2020

Dr. Fauci says COVID vaccine trials could end early if results are overwhelming

A COVID-19 vaccine could be available earlier than expected if ongoing clinical trials produce overwhelmingly positive results, said Dr. Anthony Fauci, the nation's top infectious disease official, in an interview Tuesday with KHN.

1 Sep 2020

Researchers launch study to evaluate safety of HIV prevention methods in breastfeeding women

The development of safe and effective HIV prevention methods for cisgender women has long been a global health priority, yet research in women during pregnancy and breastfeeding, when they are most vulnerable to infection, has lagged years behind.

31 Aug 2020

New insights into why people suffer from nickel allergy

The cause of the allergic reaction are T lymphocytes (T cells). These cells are part of the body's defences and normally react to viruses or bacteria in the skin.

31 Aug 2020

Researchers develop advanced imaging technique to visualize effects of valencies on B cell responses

Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.

28 Aug 2020

Study shows how genetics could improve safety and efficacy of drugs for COVID-19 treatment

Over the past few months, a number of drugs have been under investigation to treat COVID-19 without well-established safety or data to support these claims.

28 Aug 2020

Allergies News and Research

Latest Allergies News and Research

Researchers develop highly scalable, accurate antibody test for COVID-19

New study brings researchers closer to a universal COVID-19 antibody test

Most adults wary of taking any vaccine approved before the election

Allergic immune response against bacteria is not pathological but protective

Researchers receive $1.9 million federal grant to find Lyme disease vaccine

Babies born in the fall more likely to experience all conditions associated with atopic march

Convalescent plasma could be an effective treatment for children with COVID-19

Researchers discuss the role of chemical senses in disease and social interactions in humans, animals

Will Labor Day weekend bring another holiday COVID surge? Jury’s out.

As threat of valley fever grows beyond the Southwest, push is on for vaccine

Phase 3 study to test efficacy of new treatment for pediatric acute-onset neuropsychiatric syndrome

UChicago Medicine launches clinical trial to test the potential of antibody against SARS-CoV-2

Scientists identify genetic risk factors underlying penicillin allergy

HIV and HCV testing at drug detoxification centers can help identify persons at-risk during opioid epidemic

VUMC launches clinical trial of promising COVID-19 treatments in outpatient setting

Dr. Fauci says COVID vaccine trials could end early if results are overwhelming

Researchers launch study to evaluate safety of HIV prevention methods in breastfeeding women

New insights into why people suffer from nickel allergy

Researchers develop advanced imaging technique to visualize effects of valencies on B cell responses

Study shows how genetics could improve safety and efficacy of drugs for COVID-19 treatment

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in